Article Text
Commentary
Shifting bottlenecks in acute stroke treatment
Statistics from Altmetric.com
Footnotes
Competing interests MG has received consulting fee from Medtronic for conduct and design of SWIFT PRIME trial. ESCAPE trial for partly funded by Medtronic through a grant to University of Calgary. MG has developed technologies related to improving systems of stroke diagnosis that has been subsequently licensed to GE Healthcare.
Provenance and peer review Not commissioned; internally peer reviewed.